192 related articles for article (PubMed ID: 1455069)
1. In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?
Yajko DM
Res Microbiol; 1992 May; 143(4):411-9. PubMed ID: 1455069
[No Abstract] [Full Text] [Related]
2. Quantitative cultures and drug susceptibility testing of Mycobacterium avium clinical isolates before and during the antimicrobial therapy.
Heifets LB
Res Microbiol; 1994; 145(3):188-96. PubMed ID: 7809471
[No Abstract] [Full Text] [Related]
3. Control of disease progress in Mycobacterium avium-infected AIDS patients.
Hoffner SE; Källenius G; Svenson SB
Res Microbiol; 1992 May; 143(4):391-8. PubMed ID: 1455066
[No Abstract] [Full Text] [Related]
4. In-vitro evaluation of clarithromycin, temafloxacin, and ethambutol in combination against Mycobacterium avium complex.
Gevaudan MJ; Bollet C; Mallet MN; de Micco P
J Antimicrob Chemother; 1993 May; 31(5):725-30. PubMed ID: 8392998
[TBL] [Abstract][Full Text] [Related]
5. Activity of antimicrobial agents against Mycobacterium avium-intracellulare complex (MAC) strains isolated in Italy from AIDS-patients.
Fattorini L; Hu CQ; Jin SH; Santoro C; Tsang AY; Mascellino MT; Mandler F; Orefici G
Zentralbl Bakteriol; 1992 Apr; 276(4):512-20. PubMed ID: 1611208
[TBL] [Abstract][Full Text] [Related]
6. [Activity of antibiotics against pigmented and unpigmented variants of Mycobacterium avium-intracellulare].
Gevaudan MJ; Bollet C; Mallet MN; de Micco P
Pathol Biol (Paris); 1991 May; 39(5):429-35. PubMed ID: 1652731
[TBL] [Abstract][Full Text] [Related]
7. Activity of rifabutin, clarithromycin, ethambutol, sparfloxacin and amikacin, alone and in combination, against Mycobacterium avium complex in human macrophages.
Pellegrin I; Maugein J; Lapeyre C; Barbeau P; Leng B; Pellegrin JL
J Antimicrob Chemother; 1996 Mar; 37(3):501-10. PubMed ID: 9182107
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and genetic markers, virulence factors and intracellular growth of Mycobacterium avium in AIDS.
McFadden JJ; Kunze ZM; Portaels F; Labrousse V; Rastogi N
Res Microbiol; 1992 May; 143(4):423-30, discussion 430-6. PubMed ID: 1360693
[No Abstract] [Full Text] [Related]
9. Immunomodulatory events in Mycobacterium avium infections.
Denis M
Res Microbiol; 1994; 145(3):225-9. PubMed ID: 7809476
[No Abstract] [Full Text] [Related]
10. Mycobacterium avium: pathogenicity in HIV1 infection.
Shiratsuchi H; Johnson JL; Ellner JJ
Res Microbiol; 1994; 145(3):230-6. PubMed ID: 7809477
[No Abstract] [Full Text] [Related]
11. [Extracellular and intracellular activity of sparfloxacin against Mycobacterium avium complex and Mycobacterium xenopi].
Gevaudan MJ; Bollet C; Mallet MN; de Lamballerie X; Sambuc R; de Micco P
Pathol Biol (Paris); 1992 May; 40(5):443-9. PubMed ID: 1323093
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activities of clarithromycin, gatifloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex.
Tomioka H; Sano C; Sato K; Shimizu T
Int J Antimicrob Agents; 2002 Feb; 19(2):139-45. PubMed ID: 11850167
[TBL] [Abstract][Full Text] [Related]
13. In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex.
Naik S; Ruck R
Antimicrob Agents Chemother; 1989 Sep; 33(9):1614-6. PubMed ID: 2817858
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient.
von Reyn CF; Jacobs NJ; Arbeit RD; Maslow JN; Niemczyk S
J Clin Microbiol; 1995 Apr; 33(4):1008-10. PubMed ID: 7790424
[TBL] [Abstract][Full Text] [Related]
15. [Azithromycin and Mycobacterium avium infection].
Perronne C
Pathol Biol (Paris); 1995 Jun; 43(6):565-7. PubMed ID: 8539084
[TBL] [Abstract][Full Text] [Related]
16. Type frequency and antimicrobial susceptibility of Mycobacterium avium-intracellulare complex strains isolated in Italy from AIDS and non-AIDS patients.
Fattorini L; Vincent V; Li B; Xiao Y; Varnerot A; Tortoli E; Piersimoni C; Mandler F; Mascellino MT; Iona E; Orefici G
J Chemother; 1996 Feb; 8(1):37-42. PubMed ID: 8835106
[TBL] [Abstract][Full Text] [Related]
17. Killing by antimycobacterial agents of AIDS-derived strains of Mycobacterium avium complex inside cells of the mouse macrophage cell line J774.
Yajko DM; Nassos PS; Sanders CA; Hadley WK
Am Rev Respir Dis; 1989 Nov; 140(5):1198-203. PubMed ID: 2817581
[TBL] [Abstract][Full Text] [Related]
18. A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formation.
Carter G; Young LS; Bermudez LE
Antimicrob Agents Chemother; 2004 Dec; 48(12):4907-10. PubMed ID: 15561879
[TBL] [Abstract][Full Text] [Related]
19. Effects of antimicrobial agents on survival of Mycobacterium avium complex inside alveolar macrophages obtained from patients with human immunodeficiency virus infection.
Yajko DM; Nassos PS; Sanders CA; Hadley WK
Antimicrob Agents Chemother; 1991 Aug; 35(8):1621-5. PubMed ID: 1929335
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
